adenosine has been researched along with Diabetic Retinopathy in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Luo, CP; Zou, YL | 1 |
| Jalkanen, S; Kaarniranta, K; Kauppinen, A; Korhonen, AM; Lehti, K; Losenkova, K; Loukovaara, S; Müller, CE; Yegutkin, GG; Zeiner, J; Zuccarini, M | 1 |
| Ahmad, S; Al-Gayyar, MM; Eissa, LA; El-Remessy, AB; El-Shishtawy, MM; Elsherbini, AM; Elsherbiny, NM; Fulzele, S; Han, G; Haroldo, TF; Liou, GI; Mohammad, S; Naime, M; White, R | 1 |
| Ahmad, S; Al-Gayyar, MM; Eissa, LA; El-Shishtawy, MM; Elsherbini, AM; Elsherbiny, NM; Fulzele, S; Liou, GI; Naime, M | 1 |
| Cavadas, C; Correia, MB; Costa, GN; Santos, PF; Vindeirinho, J | 1 |
| Ahmad, S; El-Remessy, A; El-Sherbini, A; Fulzele, S; Liou, GI; Matragoon, S; Radhakrishnan, R; Sangani, R | 1 |
| Ambrósio, AF; Cavadas, C; Santiago, AR; Santos, PF; Vindeirinho, J | 1 |
| Aalto, K; Jalkanen, S; Liukkonen, J; Loukovaara, S; Sandholm, J; Yegutkin, GG | 1 |
| Bringmann, A; Hollborn, M; Iandiev, I; Pannicke, T; Reichenbach, A; Wiedemann, P; Wurm, A; Zimmermann, H | 1 |
| Betteridge, DJ; Cooper, MB; Gasser, JA; Saggerson, ED; Tan, KC | 1 |
| Ghiardi, GJ; Gidday, JM; Roth, S | 1 |
2 review(s) available for adenosine and Diabetic Retinopathy
| Article | Year |
|---|---|
The Adenosinergic System in Diabetic Retinopathy.
Topics: Adenosine; Animals; Cellular Microenvironment; Diabetic Retinopathy; Humans; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Retina; Signal Transduction | 2016 |
The purine nucleoside adenosine in retinal ischemia-reperfusion injury.
Topics: Adenosine; Animals; Cattle; Cloning, Molecular; Diabetic Retinopathy; Gene Expression; Guinea Pigs; Humans; Ischemia; Ischemic Preconditioning; Rats; Receptors, Purinergic P1; Reperfusion Injury; Retina; Retinal Vessels | 1999 |
9 other study(ies) available for adenosine and Diabetic Retinopathy
| Article | Year |
|---|---|
Identification of lncRNAs Associated with the Pathogenesis of Diabetic Retinopathy: From Sequencing Analysis to Validation via
Topics: Adenosine; Animals; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Endothelial Cells; Glucose; Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; RNA, Long Noncoding | 2022 |
Soluble and membrane-bound adenylate kinase and nucleotidases augment ATP-mediated inflammation in diabetic retinopathy eyes with vitreous hemorrhage.
Topics: Adenosine; Adenosine Diphosphate; Adenosine Triphosphate; Adenylate Kinase; Adult; Aged; Alkaline Phosphatase; Diabetic Retinopathy; Eye; Female; Humans; Inflammation; Male; Middle Aged; Nucleotidases; Vitreous Hemorrhage | 2019 |
Potential roles of adenosine deaminase-2 in diabetic retinopathy.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Deaminase; Animals; Cell Hypoxia; Diabetic Retinopathy; Enzyme Activation; Female; Glycated Serum Albumin; Glycation End Products, Advanced; GPI-Linked Proteins; Humans; Inflammation; Intercellular Signaling Peptides and Proteins; Microglia; Middle Aged; Receptors, Purinergic P1; Retina; RNA, Small Interfering; Serum Albumin; Signal Transduction; Swine; Tumor Necrosis Factor-alpha; U937 Cells | 2013 |
ABT-702, an adenosine kinase inhibitor, attenuates inflammation in diabetic retinopathy.
Topics: Adenosine; Adenosine A2 Receptor Antagonists; Adenosine Kinase; Animals; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Enzyme Inhibitors; Equilibrative Nucleoside Transporter 1; Glycated Serum Albumin; Glycation End Products, Advanced; Intercellular Adhesion Molecule-1; Male; Mice; Mice, Inbred C57BL; Microglia; Molecular Targeted Therapy; Morpholines; Oxidative Stress; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Retinitis; Serum Albumin; Tumor Necrosis Factor-alpha | 2013 |
Effect of diabetes/hyperglycemia on the rat retinal adenosinergic system.
Topics: Adenosine; Adenosine Deaminase; Adenosine Kinase; Animals; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Glucose; Hyperglycemia; Male; Rats; Rats, Wistar; Receptors, Purinergic P1; Retina | 2013 |
MicroRNA-146b-3p regulates retinal inflammation by suppressing adenosine deaminase-2 in diabetes.
Topics: Adaptor Proteins, Signal Transducing; Adenosine; Aged; Animals; Autopsy; Diabetic Retinopathy; DNA-Binding Proteins; Female; Gene Expression Regulation, Enzymologic; Humans; Inflammation; Male; Mice; MicroRNAs; Middle Aged; Retina; Swine; Transcription Factors; Tumor Necrosis Factor-alpha | 2015 |
Deregulation of ocular nucleotide homeostasis in patients with diabetic retinopathy.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Diphosphate; Adenosine Triphosphate; Adenylate Kinase; Adult; Aged; Chromatography, Thin Layer; Diabetic Retinopathy; Erythropoietin; Female; Humans; Male; Middle Aged; Nucleoside-Diphosphate Kinase; Retina; Statistics, Nonparametric; Vascular Endothelial Growth Factor A; Vitreous Body | 2017 |
Purinergic receptor activation inhibits osmotic glial cell swelling in the diabetic rat retina.
Topics: Adenosine; Animals; Antigens, CD; Apyrase; Cell Size; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Glucocorticoids; Male; Neuroglia; Osmosis; Oxidative Stress; Rats; Rats, Long-Evans; Rats, Wistar; Receptors, Purinergic; Retina; Reverse Transcriptase Polymerase Chain Reaction; Triamcinolone | 2008 |
Altered cellular signalling and decreased platelet sensitivity to adenosine in insulin-dependent diabetic patients with proliferative retinopathy.
Topics: Adenosine; Adenosine Diphosphate; Adenosine-5'-(N-ethylcarboxamide); Binding Sites; Blood Platelets; Cell Membrane; Colforsin; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Epoprostenol; Female; GTP-Binding Proteins; Humans; Middle Aged; Platelet Aggregation; Receptors, Purinergic; Signal Transduction | 1993 |